Infeção por SARS-CoV-2 em Moçambique: a epidemiologia e os avanços alcançados com a vacinação contra a COVID-19

Mohsin Sidat; Igor Capitine

doi:10.25761/anaisihmt.432

Mohsin Sidat Professor Associado na Faculdade de Medicina da Universidade Eduardo Mondlane (UEM), Maputo, Moçambique; Professor Associado convidado da UEI Saúde Pública Global, IHMT/ Universidade Nova de Lisboa, Portugal.
Igor Capitine Doutor em Pesquisa Médica – Saúde Internacional, Investigador do Instituto Nacional de Saúde (INS), Maputo, Moçambique

DOI: https://doi.org/10.25761/anaisihmt.432

Palavras-chave: COVID-19, epidemiologia, vacinação, Moçambique

Resumo

Desde que os primeiros casos da infecção por SARS-CoV-2 foram reportados na Cidade de Wuhan (China), mundialmente, no decurso da pandemia, foram reportadas vagas ou ondas de infeções por SARS-CoV-2, com significativo impacto na morbidade e mortalidade por COVID-19, sobretudo causadas por circulação de variantes de preocupação do vírus que emergiram ao longo do tempo, incluindo em Moçambique. Para além de medidas de Saúde Pública implementadas desde as fases inicias da pandemia, como identificação de casos e seu isolamento, encerramento das escolas e outros lugares de aglomeração de pessoas, distanciamento social e medidas de higiene e proteção individual e coletiva, foram introduzidos, ao nível global e no país, os Programas Nacionais de Vacinação Contra a COVID-19. Com a introdução da vacinação, esperava-se conseguir um controle mais eficaz da pandemia. Contudo, isso não aconteceu e ainda persistem alguns desafios. Assim, neste artigo, com base na revisão documental e dos dados epidemiológicos disponíveis nas plataformas digitais, descreve-se e compara-se a evolução da epidemia em Moçambique em relação ao continente Africano e o Mundo no geral e são avançadas algumas das possíveis explicações para a evolução observada da pandemia da COVID-19. Por outro lado, algumas considerações são apresentadas em torno dos avanços alcançados e os desafios persistentes no país e ao nível global com a introdução do programa de vacinação contra a COVID-19.

Downloads

Não há dados estatísticos.

Referências

Khalil OAK, Khalil S da S. SARS-CoV-2: taxonomia, origem e constituição. Rev. Med. (São Paulo) [Internet]. 10 de dezembro de 2020 [citado 23 de junho de 2022]; 99(5):473-9. Disponível em: https://www.revistas.usp.br/revistadc/ article/view/169595.

Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020 Aug 25; 324(8):782-793. doi: 10.1001/jama.2020.12839.

Flaxman, S., Mishra, S., Gandy, A. et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature 584, 257–261 (2020). https://doi.org/10.1038/s41586-020-2405-7.

Pan A, Liu L,Wang C, Guo H, Hao X,Wang Q, Huang J, He N,Yu H, Lin X,Wei S, Wu T. Association of Public Health Interventions with the Epidemiology of the COVID-19 Outbreak in Wuhan, China. JAMA. 2020 May 19;323(19):1915-1923. doi: 10.1001/jama.2020.6130.

McNamara LA, Wiegand RE, Burke RM, Sharma AJ, Sheppard M, Adjemian J, Ahmad FB, Anderson RN, Barbour KE, Binder AM, Dasgupta S, Dee DL, Jones ES, Kriss JL, Lyons BC, McMorrow M, Payne DC, Reses HE, Rodgers LE, Walker D, Verani JR, Schrag SJ. Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admis- sions, and deaths among adults aged 65 years and older: an ecological analysis of na- tional surveillance data. Lancet. 2022 Jan 8; 399 (10320):152-160. doi: 10.1016/ S0140-6736(21)02226-1.

Piechotta V, Harder T. Waning of COVID-19 vaccine effectiveness: individual and public health risk. Lancet. 2022 Mar 5;399(10328):887-889. doi: 10.1016/ S0140-6736(22)00282-3.

Instituto Nacional de Saúde (INS) /Ministério da Saúde (MISAU). Boletim Diá- rio No 827 - Atualização de 22 de Junho de 2022. Junho de 2022. [Consultado em 23 de junho de 2022]. Maputo, Moçambique. Disponível em: https://covid19.ins.gov.mz/wp-content/uploads/2022/06/Boletim-Diario-827.pdf

Murray CJL. COVID-19 will continue but the end of the pandemic is near. Lancet. 2022 Jan 29;399(10323):417-419. doi: 10.1016/S0140-6736(22)00100-3.

COVID-19 Cumulative Infection Collaborators. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis. Lancet. 2022 Apr 8;399(10344):2351–80. doi: 10.1016/S0140-6736(22)00484-6.

Programa Alargado de Vacinação, Direção Nacional de Saúde Pública, Minis- tério da Saúde. Plano Nacional de Vacinação Contra a COVID-19. Março de 2021. Maputo: Ministério da Saúde Disponível em: https://www.misau.gov.mz/index.php/covid-19-planos-nacionais-e-vacinacao# (consultado a 23/06/2022).

Assefa, Y., Gilks, C.F., Reid, S. et al. Analysis of the COVID-19 pandemic: lessons towards a more effective response to public health emergencies. Global Health 18, 10 (2022). https://doi.org/10.1186/s12992-022-00805-9.

Wamai RG, Hirsch JL, Van Damme W, Alnwick D, Bailey RC, Hodgins S, Alam U, Anyona M. What Could Explain the Lower COVID-19 Burden in Africa despite Considerable Circulation of the SARS-CoV-2 Virus? Int J Environ Res Public Health. 2021 Aug 16;18(16):8638. doi: 10.3390/ijerph18168638.

Silva, Catia Antonia da; Monie, Frédéric; Mulhaisse, Raimundo Alberto. Coronavirus/ COVID-19 pandemic in Mozambique: challenges for reflection on the territorial and socioeconomic contexts of Health policy. Geosaberes 11, 674 - 692 (2020). doi: https://doi.org/10.26895/geosaberes.v11i0.1101. Disponível em: http://www.geosaberes.ufc.br/geosaberes/article/view/1101. Consultado a 23 junho 2022.

COVID-19 Forecasting Team. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis. Lancet. 2022 Apr 16;399(10334):1469-1488. doi: 10.1016/S0140- 6736(21)02867-1.

Denhard L, Kaviany P, Chicumbe S, Muianga C, Laisse G, Aune K, Sheffel A. How prepared is Mozambique to treat COVID-19 patients? A new approach for estimating oxygen service availability, oxygen treatment capacity, and population ac- cess to oxygen-ready treatment facilities. Int J Equity Health. 2021 Apr 6;20(1):90. doi: 10.1186/s12939-021-01403-8.

Jassat W, Abdool Karim SS, Mudara C, Welch R, Ozougwu L, Groome MJ, Govender N, von Gottberg A, Wolter N, Wolmarans M, Rousseau P; DATCOV author group, Blumberg L, Cohen C. Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study. Lancet Glob Health. 2022 Jul;10(7):e961-e969. doi: 10.1016/ S2214-109X(22)00114-0.

Karamagi HC, Tumusiime P, Titi-Ofei R, et al. Towards universal health cove- rage in the WHO African Region: assessing health system functionality, incorporating lessons from COVID-19. BMJ Global Health 2021;6:e004618. doi:10.1136/bmjgh-2020-004618.

Das Neves Martins Pires PH, Macaringue C, Abdirazak A, Mucufo JR, Mu- pueleque MA, Zakus D, Siemens R, Belo CF. Covid-19 pandemic impact on maternal and child health services access in Nampula, Mozambique: a mixed methods research. BMC Health Serv Res. 2021 Aug 23;21(1):860. doi: 10.1186/s12913- 021-06878-3.

Barletta G, Castigo F, Egger EM, Keller M, Salvucci V, Tarp F. The impact of COVID-19 on consumption poverty in Mozambique. J Int Dev. 2022 May;34(4):771- 802. doi: 10.1002/jid.3599.

Betho R, Chelengo M, Jones S, Keller M, Mussagy IH, van Seventer D, Tarp F. The macroeconomic impact of COVID-19 in Mozambique: A social accounting matrix approach. J Int Dev. 2022 May;34(4):823-860. doi: 10.1002/jid.3601.

Lima AV. Facing COVID-19 in times of armed conflicts in Northern and Central regions of Mozambique. J Public Health Policy. 2021 Sep;42(3):510-513. doi: 10.1057/s41271-021-00300-2.

Júnior A, Dula J, Mahumane S, Koole O, Enosse S, Fodjo JNS, Colebunders R. Adherence to COVID-19 Preventive Measures in Mozambique: Two Consecutive Online Surveys. Int J Environ Res Public Health. 2021 Jan 26;18(3):1091. doi: 10.3390/ijerph18031091.

Lane J, Means AR, Bardosh K, Shapoval A, Vio F, Anderson C, Cushnie A, Forster N, Ledikwe J, O’Malley G, Mawandia S, Parvez A, Perrone L, Muden- der F. Comparing COVID-19 physical distancing policies: results from a physical distancing intensity coding framework for Botswana, India, Jamaica, Mozambique, Namibia, Ukraine, and the United States. Global Health. 2021 Oct 23;17(1):124. doi: 10.1186/s12992-021-00770-9.

Dula J, Mulhanga A, Nhanombe A, Cumbi L, Júnior A, Gwatsvaira J, Fodjo JNS, Faria de Moura Villela E, Chicumbe S, Colebunders R. COVID-19 Vaccine Acceptability and Its Determinants in Mozambique: An Online Survey. Vaccines (Basel). 2021 Jul 27;9(8):828. doi: 10.3390/vaccines9080828.

Nachega JB, Sam-Agudu NA, Masekela R, van der Zalm MM, Nsanzimana S, Condo J, Ntoumi F, Rabie H, Kruger M, Wiysonge CS, Ditekemena JD, Chirimwami RB, Ntakwinja M, Mukwege DM, Noormahomed E, Paleker M, Mahomed H, Tamfum JM, Zumla A, Suleman F. Addressing challenges to rolling out COVID-19 vaccines in African countries. Lancet Glob Health. 2021 Jun;9(6):e746-e748. doi: 10.1016/S2214-109X(21)00097-8.

McIntyre PB, Aggarwal R, Jani I, Jawad J, Kochhar S, MacDonald N, Madhi SA, Mohsni E, Mulholland K, Neuzil KM, Nohynek H, Olayinka F, Pitisuttithum P, Pollard AJ, Cravioto A. COVID-19 vaccine strategies must focus on severe di- sease and global equity. Lancet. 2022 Jan 22;399(10322):406-410. doi: 10.1016/ S0140-6736(21)02835-X.

Amouzouvi K, Assamagan KA, Azote S, Connell SH, Fankam JBF, Fanome- zana F, Guga A, Haliya CE, Mabote TS, Macucule FF, Mathebula D, Muronga A, Mwale KCC, Njeri A, Onyie EF, Rakotondravohitra L, Zimba G. A model of CO- VID-19 pandemic evolution in African countries. Sci Afr. 2021 Nov;14:e00987. doi: 10.1016/j.sciaf.2021.e00987.